Work

Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide

Year: 2004

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-004-0894-y

Authors: N. Germann, S. Urien, Andrew H. Rodgers, Marion Ratterree, Robert F. Struck, William R. Waud, David G. Serota, Gerard Bastian, Branko S. Jursic, Lee Roy Morgan

Institutions: Hôpital René Huguenin, DEKK-TEC (United States), Tulane University, Southern Research Institute, MPI Research (United States), LSU New Orleans

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Tulane University, National Institutes of Health, National Cancer Institute

Awards: ISOPHOSPHORAMIDE MUSTARD ANALOGS FOR CANCER THERAPY, G4952875528, G5862785795, ISOPHOSPHORAMIDE MUSTARD--A PHASE 1 STUDY

OpenAlex ID: W2091995851

FWCI: 0.237

Cites: 14

Cited by: 12

Related to: 10